{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-112436","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.140906+00:00","generated_at":"2026-06-22T22:37:33.753233+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"iSpecimen finalizes CEO/COO departures, enters new employment agreements with Curley and Bielak; director resigns","bullets":["Former CEO Ianelli receives $350,000 severance and accelerated vesting of 13,021 RSUs; COO Mullan gets $325,000 severance and 13,021 RSUs.","Tracy Curley appointed Interim CEO/CFO with annual salary of $350,000 and target bonus of 50% of salary (25% prorated for 2022).","CIO Benjamin Bielak gets amended agreement with $326,000 salary, 40% target bonus (20% prorated for 2022), and 30,000 stock options.","Director Margaret Lawrence resigns effective November 15, 2022 for personal reasons; no disagreement with the company.","Executives Curley and Bielak receive stock option grants: 100,000 shares and 30,000 shares, respectively, vesting over four years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-112436","json":"https://secwatch.observer/filing/0001104659-22-112436.json","markdown":"https://secwatch.observer/filing/0001104659-22-112436.md","text":"https://secwatch.observer/filing/0001104659-22-112436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922112436/0001104659-22-112436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922112436/tm2229013d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:37:33.753233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"55d7ee50cc","claim":"Margaret H. Lawrence resigned as director at iSpecimen Inc..","evidence_excerpt":"On October 27, 2022, Margaret H. Lawrence informed the Board of her intention to resign as a director of the Company effective November 15, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465922112436/0001104659-22-112436-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}